← All trials
NCT05767866
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 30, 2018
- Primary completion
- Dec 30, 2023
- Completion date
- May 30, 2024
- First posted
- Mar 14, 2023
- Last posted
- Mar 17, 2023
- Enrollment
- 160
- Arms / groups
- 10 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of ChinaLead sponsor
- Government of ChinaStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.